Unique dose monitoring RadiaDyne offers OARtrac, a novel real-time radiation dose monitoring platform with intracavitary delivery devices, presenting a high-value upsell to clinics seeking adaptive radiotherapy and improved tumor targeting.

Balloon tech leadership With established balloon-based stabilization products like ImmobiLoc and Alatus Vaginal Balloon Packing, RadiaDyne can cross-sell to centers aiming to minimize healthy tissue exposure and enhance patient comfort during radiotherapy.

Regulatory edge Alatus is FDA-cleared, signaling a credible regulatory footprint that can simplify procurement discussions and speed adoption in compliant clinics and hospital systems.

Early market traction Historical awards and early launches (OARtrac in 2018-2019) indicate a proven interest from the medtech community, suggesting a receptive buyer base among oncology departments and medical device distributors.

Growth through partnerships RadiaDyne’s profile aligns with mid-market medical device distributors and larger oncology players; pursuing channel partnerships could accelerate coverage, expand install bases, and drive revenue toward the higher end of the market.